diagnosis or history of type 1 diabetes or secondary forms of diabetes

acute metabolic diabetic complications within past 6 months

severe hypoglycemia \</=1 month prior to screening

clinically significant gastrointestinal disease

history of chronic or acute pancreatitis

current New York Heart Association (NYHA) class IV heart failure or post-transplantation cardiomyopathy

severely impaired renal function

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease